in

DARPA Taps Sorrento for COVID-19 Rapid Countermeasure Effort

DARPA Taps Sorrento for COVID-19 Rapid Countermeasure Effort - top government contractors - best government contracting event
Sorrento

A subsidiary of Sorrento Therapeutics has landed a potential $34M contract from the Defense Advanced Research Projects Agency to produce a rapid countermeasure against COVID-19.

SmartPharm Therapeutics will encode the STI-2020 SARS-CoV-2 neutralizing antibody into a plasmid DNA that will be incorporated into the Gene MAb platform, Sorrento said Friday.

DARPA seeks to speed up the development of an antibody that will support intramuscular injection and provide recipients with potent neutralizing antibodies to mitigate potential SARS-CoV-2 mutations.

"We look forward to working with our Department of Defense partners to potentially add a novel approach to the arsenal of solutions for combating this devastating disease," said Henry Ji, Sorrento CEO.

The award provides for the project's phase two clinical studies. Sorrento plans to apply for further funding to drive large-scale manufacturing efforts and secure an emergency use authorization approval for Gene MAb.

ExecutiveBiz Logo

Sign Up Now! ExecutiveBiz provides you with Daily Updates and News Briefings about Technology

mm

Written by Matthew Nelson

Databricks Gets FedRAMP OK for Unified Data Analytics System - top government contractors - best government contracting event
Databricks Gets FedRAMP OK for Unified Data Analytics System
Jonas Furukrona LVC Training VP
USAF Demos Cubic-Made Mission Analysis Software at Checkered Flag Exercise; Jonas Furukrona Quoted